A survey of international guidelines for bioequivalence of systemically available orally administered generic drug products
- Author:
Feng-Chang ZHU
1
Author Information
- Publication Type:Journal Article
- Keywords: Analytes measure; Bioequivalence; Biowaivers; Orally administered generic drug product
- From: Chinese Pharmaceutical Journal 2016;51(20):1807-1814
- CountryChina
- Language:Chinese
- Abstract: OBJECTIVE: To investigate similarities and differences among bioequivalence approaches used by international regulatory authorities when reviewing applications for marketing new generic drug products which are systemically active and intended for oral administration. METHODS: The comparisons of these bioequivalence recommendations were performed and based on bioequivalence study designs, selection of bioequivalence subjects,dosage, selection of reference products, method of pharmacokinetic calculations and bioequivalence acceptance limits, bioequivalence waiver on multiple-strength products and and implementation of the Biopharmaceutics Classification System, which are issued by Australia, the European Medicines Association, Japan,the USA, and the World Health Organization. RESULTS: There were lots of differences were found in bioequivalence approaches among the regulatory authorities surveyed, although there are more similarities. CONCLUSION: Discussion of the similarities and differences among bioequivalence approaches used by international regulatory authorities would provide instructive and practical assists to the equivalence assessment of quality and curative effect for generic products in China.
